Structures by: Reddy O. G.

Total: 13

Venlafaxine hydrocloride

C17H28NO2,Cl

A. Sivalakshmidevi K. Vyas S. Mahender Rao G. Om Reddy

Acta Crystallographica Section E (2002) 58, 10 o1072-o1074

a=5.797(6)Å   b=26.074(7)Å   c=11.722(3)Å

α=90°   β=100.72(5)°   γ=90°

C21H20F3N3O5S

C21H20F3N3O5S

K. VyasA. SivalakshmideviS. K. SinghY. Koteswar RaoG. Om Reddy

Acta Crystallographica Section E (2003) 59, 11 o1731-o1732

a=10.4490(8)Å   b=12.0126(8)Å   c=9.2196(9)Å

α=111.068(6)°   β=94.851(7)°   γ=86.328(6)°

Gemcitabine Hydrochloride

C9H12F2N3O41,Cl1

A. SivalakshmideviK. VyasS. D. V. N. SivaramP. Veerabhadra SwamyRamachandra PuranikP. Sairam G. Om Reddy

Acta Crystallographica Section E (2003) 59, 10 o1435-o1437

a=11.4680(7)Å   b=15.5987(9)Å   c=6.706(2)Å

α=90°   β=90°   γ=90°

8-methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]- imidazo[1,2-a][1,3]benzimidazol-2(12H)-one

C16H13N3O2S

Moses Babu, J.Vyas, K.Prabhakar, C.Sreenivas Rao, D.Om Reddy, G.

Acta Crystallographica Section C (1999) 55, 12 IUC9900162

a=7.002(2)Å   b=18.442(5)Å   c=11.443(2)Å

α=90°   β=102.72(2)°   γ=90°

4-[4-Acetyloxy-3,5,6-trimethyl-1-[4-nitrobenzoyl]oxy-2-yl]butan-2-one

C22H23NO7

Prabhakar, C.Vyas, K.Moses Babu, J.Sarma, M. R.Om Reddy, G.

Acta Crystallographica Section C (1999) 55, 12 IUC9900160

a=12.1860(10)Å   b=8.7763(9)Å   c=20.4128(9)Å

α=90°   β=104.593(4)°   γ=90°

Celecoxib

C17H14F3N3O2S

Vasu Dev, R.Shashi Rekha, K.Vyas, K.Mohanti, S. B.Rajender Kumar, P.Om Reddy, G.

Acta Crystallographica Section C (1999) 55, 12

a=10.136(5)Å   b=16.778(6)Å   c=5.066(6)Å

α=97.62(7)°   β=100.65(6)°   γ=95.95(4)°

Troglitazone

C24H27NO5S

K. VyasA. SivalakshmideviC. PrabhakarG. Om Reddy

Acta Crystallographica Section C (1999) 55, 3 411-413

a=16.239(3)Å   b=11.717(3)Å   c=11.627(4)Å

α=90°   β=93.69(2)°   γ=90°

C25H28N2O4

C25H28N2O4

K. VyasK. Shashi RekhaP. Rajender KumarS. RajuM. R. SarmaG. Om Reddy

Acta Crystallographica Section C (1999) 55, 7 IUC9900077

a=11.938(8)Å   b=24.421(5)Å   c=7.8395(12)Å

α=90°   β=90°   γ=90°

C23H38N2O2,C1H4O1

C23H38N2O2,C1H4O1

Ravindra Kumar, Y.Vyas, K.Om Reddy, G.Rajan, S. T.Reddy, M. S. N.

Acta Crystallographica Section C (1999) 55, 9 IUC9900105

a=11.607(2)Å   b=20.097(5)Å   c=10.449(4)Å

α=90°   β=90°   γ=90°

C22H25Cl1N5O21,C4H3O41,2.5H2O1

C22H25Cl1N5O21,C4H3O41,2.5H2O1

Vyas, K.Moses Babu, J.Om Reddy, G.

Acta Crystallographica Section C (1999) 55, 9 IUC9900104

a=6.676(5)Å   b=24.324(7)Å   c=17.660(10)Å

α=90°   β=95.87(6)°   γ=90°

Sparfloxacin

C19H22F2N4O3,3H2O1

Sivalakshmidevi, A.Vyas, K.Om Reddy, G.

Acta Crystallographica Section C (2000) 56, 3 e115-e116

a=11.850(3)Å   b=10.913(4)Å   c=17.506(2)Å

α=90°   β=107.760(10)°   γ=90°

Lansoprazole

C16H14F3N3O2S

Vyas, K.Sivalakshmidevi, A.Om Reddy, G.

Acta Crystallographica Section C (2000) 56, 12 e572-e573

a=15.8700(10)Å   b=7.3481(8)Å   c=14.2620(10)Å

α=90.00°   β=102.032(5)°   γ=90.000°

4-(4-methylsulfonylphenyl)-3-phenyl-2,5-dihydro-2-furanone

C17H14O4S

Shashi Rekha, K.Vyas, K.Haricharan Raju, C. M.Chandrashekar, B.Om Reddy, G.

Acta Crystallographica Section C (2000) 56, 2 e68-e68

a=11.374(2)Å   b=11.3740Å   c=22.939(3)Å

α=90°   β=90°   γ=90°